Drug-eluting coronary stents: insights from preclinical and pathology studies
Drug-eluting coronary stents: insights from preclinical and pathology studies
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Implantation of drug-eluting stents (DES) is the dominant treatment strategy for patients with symptomatic coronary artery disease. However, the first-generation DES had substantial drawbacks, including delayed healing, local hypersensitivity reactions and neoatherosclerosis, which all led to a steady increase in major adverse cardiovascular events...
Alternative Titles
Full title
Drug-eluting coronary stents: insights from preclinical and pathology studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2265767551
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2265767551
Other Identifiers
ISSN
1759-5002
E-ISSN
1759-5010
DOI
10.1038/s41569-019-0234-x
